Public Policy & Health for Substance Exposed Infant-Mother Dyads
公共政策
基本信息
- 批准号:10643277
- 负责人:
- 金额:$ 15.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-15 至 2028-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAffectAmendmentAwardBirthBlack raceCaringCause of DeathChildChild Abuse and NeglectChild RearingChild WelfareChild abuse preventionClinicalCollaborationsCommunitiesComplexConnecticutCriminal JusticeDataData AnalysesData CollectionData SetData SourcesDevelopment PlansDiagnosisEarly identificationEnsureEpidemiologyFamilyFoundationsHealthHealth PersonnelHealth PolicyHomeHospitalsIndigenousInfantInfant HealthInfrastructureInterventionIntervention StudiesJusticeLeadLinkLongitudinal SurveysMasksMaternal Health ServicesMentored Research Scientist Development AwardMentorshipModelingMothersNational Institute of Drug AbuseNeonatal Abstinence SyndromeNewborn InfantOutcomePerinatalPoliciesPolicy ResearchPopulationPopulation HeterogeneityPositioning AttributePregnancyPrevention ResearchProductivityProviderPublic HealthPublic PolicyRecordsResearchResearch PersonnelResearch PriorityRiskRoleSafetyServicesSiteStatistical MethodsSubstance Use DisorderSystemTestingTimeTrainingVulnerable PopulationsWomanWorkadministrative databaseadverse outcomecareer developmentchild protectionchild protective serviceethnic disparityexperiencefamily supportfetal substance exposurefoster caregenetic linkage analysishealth care service utilizationhealth service usehigh riskimprovedimproved outcomeinnovationmaternal outcomeminority childrenmultidisciplinarymultilevel analysisopioid overdoseperinatal womenpregnantpreventprogramsracial disparityrecruitreferral servicesresponsesafety outcomessecondary analysisservice interventionsubstance usesubstance use treatmenttheories
项目摘要
Prenatal substance exposure is a significant public health problem affecting 10% of infants (over 360,000 in
2020). Criminal justice-oriented policies enacted to protect these newborns are associated with negative
consequences for both the mother and infant, suchas lower rates of maternal substanceuse treatment utilization
in pregnancy, higher rates of neonatal opioid withdrawal syndrome (NOWS) diagnoses at birth, and
disproportionately higher child protective services (CPS) referral rates for Black and Indigenous infants. On the
other hand, states without substance-exposed infant policy lack infrastructure for systematic responses to
support these families. In 2016, the primary U.S. child welfare policy—the Child Abuse Prevention and Treatment
Act (CAPTA)—was amended to increase mother-infant health and substance use treatment utilization while
ensuring infant safety by mandating that all dyads receive a plan of safe care. Seeking to protect dyads from
intensive surveillance and threat of foster care placement, in 2019 Connecticut became the only state to use a
“masked” approach that requires plans be developed by community providers with perinatal mothers without
disclosing their identifiable information to CPS.
Dr. Margaret Lloyd Sieger is one of a small handful of researchers in the U.S. working to identify how public
health policy can increase health and safety for substance exposed infant-mother dyads. Her preliminary
research in Connecticut indicates that providers are developing plans with mothers. With this K01 award and
support from three state agencies, two large birthing hospitals, and a multidisciplinary mentorship team of
national experts, Dr. Lloyd Sieger will apply a theory of health services utilization to examine the effect of plans
of safe care on: (1) substance use treatment utilization, (2) child safety, and (3) racial disparities in CPS
involvement. The proposed project will achieve its aims using innovative, scientifically rigorous approaches to
linking three state administrative databases and recruiting mothers at the time they develop a plan of safe care
for a longitudinal survey. This K01 award will provide Dr. Lloyd Sieger with training and experience in: (1)
pertinent, multisystem clinical issues, (2) longitudinal survey research with perinatal mothers, (3) statistical
methods for multi-system data linkage and multilevel analysis, and (4) collaborations for multi-site, multi-state
research. This award will also lead to an R01 proposal to conduct a multi-site, multi-state study on plans of safe
care, thereby addressing NIDA’s priorities to understand effective policies that prevent child welfare system
involvement for mothers with substance use disorders and infants with prenatal substance exposure. Finally,
this award will set the foundation for Dr. Lloyd Sieger’s productive, independent program of research that
integrates substance use epidemiology, policy, and clinical interventions to improve outcomes for pregnant and
parenting mothers with substance use disorder and their infants.
产前物质暴露是一个重大的公共卫生问题,影响 10% 的婴儿(美国超过 360,000 名婴儿)
2020)。为保护这些新生儿而制定的以刑事司法为导向的政策与负面影响有关。
对母亲和婴儿的影响,例如母亲药物滥用治疗利用率较低
怀孕期间,出生时诊断出新生儿阿片类药物戒断综合征 (NOWS) 的比例较高,以及
黑人和土著婴儿的儿童保护服务 (CPS) 转介率不成比例地较高。
另一方面,没有针对婴儿接触物质政策的国家缺乏系统性应对措施的基础设施
2016 年,美国的主要儿童福利政策——儿童虐待预防和治疗。
法案 (CAPTA)——经过修订,以提高母婴健康和药物滥用治疗的利用率,同时
要求所有二人接受安全护理计划,以确保婴儿安全。
由于密集的监视和寄养安置的威胁,康涅狄格州于 2019 年成为唯一一个使用
“掩盖”方法,要求社区提供者在没有围产期母亲的情况下制定计划
向 CPS 披露其身份信息。
玛格丽特·劳埃德·西格 (Margaret Lloyd Sieger) 博士是美国少数研究人员之一,致力于确定公众如何
卫生政策可以提高接触物质的婴儿和母亲的健康和安全。
康涅狄格州的研究表明,提供者正在与母亲一起制定计划,并获得 K01 奖项。
来自三个国家机构、两家大型分娩医院以及多学科指导团队的支持
国家专家 Lloyd Sieger 博士将应用卫生服务利用理论来检验计划的效果
安全护理的以下方面:(1) 物质使用治疗利用,(2) 儿童安全,以及 (3) CPS 中的种族差异
拟议的项目将使用创新的、科学严谨的方法来实现其目标。
连接三个国家行政数据库并在制定安全护理计划时招募母亲
该 K01 奖项将为 Lloyd Sieger 博士提供以下方面的培训和经验:(1)
相关的多系统临床问题,(2) 围产期母亲的纵向调查研究,(3) 统计
多系统数据联动和多层次分析方法,以及(4)多地点、多状态的协作
该奖项还将引发一项 R01 提案,即对安全计划进行多地点、多州研究。
照,从而解决 NIDA 的优先事项,以了解阻碍儿童福利制度的有效政策
患有物质使用障碍的母亲和产前物质暴露的婴儿的参与。
该奖项将为 Lloyd Sieger 博士富有成效的独立研究计划奠定基础
整合物质使用流行病学、政策和临床干预措施,以改善孕妇和儿童的结局
养育患有药物滥用障碍的母亲及其婴儿。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A Comparison of Two Statewide Datasets to Understand Population Prevalence of Substance Use in Pregnancy: Findings and Considerations for Policy & Research.
比较两个全州范围内的数据集,以了解怀孕期间药物使用的人口流行率:调查结果和政策考虑因素
- DOI:
- 发表时间:2024-06
- 期刊:
- 影响因子:2.3
- 作者:Sieger, Margaret Lloyd;Morin, Jennifer C;Budris, Lisa M;Sienna, Melissa;Ostfeld;Hart, Lou;Morosky, Christopher
- 通讯作者:Morosky, Christopher
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Margaret Lloyd Sieger其他文献
Margaret Lloyd Sieger的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
基于lncRNA NONHSAT042241/hnRNP D/β-catenin轴探讨雷公藤衍生物(LLDT-8)对类风湿关节炎滑膜成纤维细胞功能影响及机制研究
- 批准号:82304988
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
针刺手法和参数对针刺效应启动的影响及其机制
- 批准号:82305416
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
二仙汤影响肾上腺皮质-髓质激素分泌及调控下丘脑温度感受器以缓解“天癸竭”潮热的研究
- 批准号:82374307
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
固定翼海空跨域航行器出水稳定性与流体动力载荷影响机制
- 批准号:52371327
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
经济制裁对跨国企业海外研发网络建构的影响:基于被制裁企业的视角
- 批准号:72302155
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase
使用 T 型钙通道和可溶性环氧化物水解酶的活性 IND 双重抑制剂开发治疗酒精使用障碍的新型药物
- 批准号:
10815882 - 财政年份:2023
- 资助金额:
$ 15.44万 - 项目类别:
BIOLOGICS SUBJECT MATTER EXPERT (SME) CONSULTING SERVICES
生物制品主题专家 (SME) 咨询服务
- 批准号:
10829326 - 财政年份:2022
- 资助金额:
$ 15.44万 - 项目类别:
BIOLOGICS SUBJECT MATTER EXPERT (SME) CONSULTING SERVICES
生物制品主题专家 (SME) 咨询服务
- 批准号:
10719224 - 财政年份:2022
- 资助金额:
$ 15.44万 - 项目类别:
TELE Para DM: Telemedicine Equity for Limited English Proficient Patients with Diabetes Mellitus in the Safety Net
TELE Para DM:安全网中英语水平有限的糖尿病患者的远程医疗公平性
- 批准号:
10598472 - 财政年份:2022
- 资助金额:
$ 15.44万 - 项目类别:
Bioinspired Green Glycolipids as Fugitive Dust Mitigation Agents
仿生绿色糖脂作为扬尘减排剂
- 批准号:
10484307 - 财政年份:2022
- 资助金额:
$ 15.44万 - 项目类别: